Trials / Conditions / Recurrent GBM
Recurrent GBM
5 registered clinical trials studyying Recurrent GBM.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM NCT05370508 | SonALAsense, Inc. | Phase 1 / Phase 2 |
| Terminated | Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab NCT04681677 | Xoft, Inc. | Phase 2 |
| Terminated | Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT NCT04763031 | Parkridge Medical Center | N/A |
| Completed | A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade NCT03234595 | Everfront Biotech Co., Ltd. | Phase 1 / Phase 2 |
| No Longer Available | Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut NCT03068650 | Celldex Therapeutics | — |